Canrong Wu
Shanghai Jiao Tong University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Sciences(CN)Ruijin Hospital(CN)Shanghai Institute of Materia Medica(CN)Southern Medical University(CN)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, SARS-CoV-2 and COVID-19 Research, Cancer, Hypoxia, and Metabolism, Monoclonal and Polyclonal Antibodies Research, Neuropeptides and Animal Physiology
Most-Cited Works
- → Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods(2020)2,451 cited
- → Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody(2022)299 cited
- → Furin: A Potential Therapeutic Target for COVID-19(2020)191 cited
- → Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP(2021)175 cited
- → Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19(2022)140 cited
- → Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis(2020)93 cited